Are Circulating Tumor Cells (CTCs) Ready for Clinical Use in Breast Cancer? An Overview of Completed and Ongoing Trials Using CTCs for Clinical Treatment Decisions

In recent years, breast cancer treatment has become increasingly individualized. Circulating tumor cells (CTCs) have the potential to move personalized medicine another step forward. The prognostic relevance of CTCs has already been proven both in early and metastatic breast cancer. In addition, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Schochter, Fabienne, Friedl, Thomas W. P., deGregorio, Amelie, Krause, Sabrina, Huober, Jens, Rack, Brigitte, Janni, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912467/
https://www.ncbi.nlm.nih.gov/pubmed/31717458
http://dx.doi.org/10.3390/cells8111412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912467/
https://www.ncbi.nlm.nih.gov/pubmed/31717458
http://dx.doi.org/10.3390/cells8111412

Ejemplares similares